This report is the result of WealthInsight’s extensive research covering the high net worth individual (HNWI) population and wealth management market in Poland.
Summary
This report provides the latest asset allocations of Polish HNWIs across 13 asset classes. The report also includes projections of the volume, wealth and asset allocation of Polish HNWIs to 2017 and a comprehensive and robust background of the local economy.
Scope
Independent market sizing of Polish HNWIs across five wealth bands
HNWI volume, wealth and allocation trends from 2007 to 2012
HNWI volume, wealth and allocation forecasts to 2017
HNWI and UHNWI asset allocations across 13 asset classes
Insights into the drivers of HNWI wealth
Reasons To Buy
The WealthInsight Intelligence Center Database is an unparalleled resource and the leading resource of its kind. Compiled and curated by a team of expert research specialists, the Database comprises profiles on major private banks, wealth managers and family offices in each country.
The WealthInsight Intelligence Center Database also includes up to one hundred data-points on over 100,000 HNWIs from around the world.
With the Database as the foundation for our research and analysis, we are able obtain an unsurpassed level of granularity, insight and authority on the HNWI and wealth management universe in each of the countries and regions we cover.
Report includes comprehensive forecasts to 2017.
Key Highlights
There are just over 28,400 HNWIs in Poland in 2012. These HNWIs hold US$139 billion in wealth which equates to 16% of total individual wealth held in the country.
In 2012, equities were the largest asset class for HNWIs in Poland (31% of total HNWI assets), followed by business interests (24.8%), real estate (19.0%), fixed income (14.3%), cash (6.8%) and alternatives (4.6%).
Business interest and fixed-income products recorded the strongest growth over the review period, driven by new business formation and a movement to safer asset classes. Equities and real estate registered the weakest performance.
Over the forecast period, alternatives are expected to be the top-performing asset class for HNWIs, followed by equities and real estate. As a result, there will be a movement away from cash and towards alternatives.
As of 2012, HNWI liquid assets amounted to US$23 billion, representing approximately 16.3% of the wealth holdings of Polish HNWIs.
WealthInsight’s research showed that in 2012, 36% of Polish HNWIs have second homes abroad. The largest destinations for these homes include Geneva, Zurich, Paris and London.
At the end of 2012, Polish HNWIs held 30.6% (US$42 billion) of their wealth outside of Poland, which is well above the norm for worldwide HNWIs of between 20% and 30%.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218695.
Contact sales@reportsandreports.com for further information.
Feb 7, 2013
Central and Eastern Europe Medical Devices Industry Research Report
The countries of Central and Eastern Europe represented a total market of 302 million people and a combined GDP of US$3.3 trillion in 2012.
Central & Eastern Europe is composed of a diverse range of markets, all at different stages of development. Markets throughout the region grew very rapidly until 2008, as many countries joined the EU between 2004 and 2007. All have healthcare systems in great need of renovation and updating, and spending on new diagnostic equipment in particular has been very strong. Most new equipment is imported, as Russia, Poland, the Czech Republic, Ukraine and Hungary represent the five largest markets in the region. Slovenia is a small market, but has the highest per capita expenditure, on a par with much of Western Europe.
The Economic Situation
All countries in the CEE region were affected by the global economic crisis to some extent; Ukraine was particularly hard hit with its economy contracting by 14.8% in 2009. However, most of the region emerged from recession in 2010 and all CEE countries were exhibiting positive growth rates by 2011. The regional economy is expected to grow by an annual average of 3.1% between 2012 and 2016, although the ongoing eurozone crisis may negatively impact this rate. The CEE region contains export-dependent countries such as the Czech Republic and Hungary, which will be vulnerable to any depressed demand in the eurozone. However, financial assistance provided by the IMF has helped countries such as Romania to strengthen their economies and limit the effects of the recession on the health sector; overall demand for medical devices has therefore remained strong, particularly in the consumables field.
Regional Health Expenditure
Total health expenditure for the CEE region is projected to reach an estimated US$329.0 billion by 2016, equal to 6.7% of GDP. At present, only 29% of spending in the region is private, but over 85% of this is composed of out-of-pocket payments. The area of private healthcare plans remains largely undeveloped within most markets. Slovenia, the wealthiest country per capita in the region, is the only state in which private plans have become a strong feature, representing almost half of total private spending.
Focus on market opportunities: Diagnostic Imaging
The table below shows the rise in demand for imported diagnostic imaging equipment since the end of the economic crisis, following a period of slow-moderate growth. Between 2006 and 2010, the CAGR for such equipment did not exceed 20% in the countries listed below; however, import performance was much more encouraging in the year ending October 2011, particularly in Romania and Poland where growth rates reached 47.8% and 34.0%, respectively. Only modest growth was observed in the Czech Republic and Slovakia, however. It will take time for countries such as Ukraine to return to pre-crisis growth rates; renewed investment in high-tech equipment will ensue as their economies strengthen.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=53537.
Highlights from the region
CZECH REPUBLIC
The Czech Republic was one of the larger and richer former Soviet countries to join the EU in May 2004. Its regulation and trade rules are now generally aligned to EU standards. It is well-located in central Europe and has an estimated population of 10.5 million in 2011. Healthcare funding is largely public, and mainly through health insurance. Private spending only accounts for an estimated 16.6% of total health expenditure in 2011. Provision of care is also largely public; the Czech Republic has yet to develop a substantial private sector. Around 80% of the Czech Republic medical device market is supplied by imports, which have risen rapidly in the past decade. In 2011, 35.7% were sourced from Germany. Other major suppliers were the Netherlands, Belgium, Switzerland and France. In 2011, imports rose by 6.6% over 2010 and by a 2007-2011 CAGR of 8.2%.
HUNGARY
In 2011, the Hungarian market for medical equipment and supplies is estimated at US$573 million, or US$58 per capita. The market value has stalled since 2008, but it is expected that it will bounce back to expand at a CAGR of 4.5% per annum in the 2011-16 period, reaching US$715 million by 2016, equal to US$73 per capita.
Around 84% of the medical device market is supplied by imports. Most are sourced from the European Union, principally the Netherlands and Germany. There is a sizeable domestic production sector, with X-ray apparatus as a particular historic specialty, but this is largely geared towards export markets.
POLAND
The size of the private healthcare sector is slowly expanding. The availability of private facilities improved significantly in 2000, when bed numbers increased three-fold. Around a quarter of health expenditure is private, although out-of-pocket payments account for most of this. In 2011, the Polish market for medical equipment and supplies is estimated at US$2,013.4 million, or US$53 per capita. The market experienced rapid growth until the end of 2008, but imports fell back sharply in the early part of 2009. The economic downturn has so far proved short, however, with growth resuming in 2010, albeit at a slightly lower rate than in previous years. Around 85% of the Polish medical device market is supplied by imports. Germany and the Netherlands were the leading suppliers in 2011, together accounting for around nearly half of imports. Germany was the leading supplier of most categories of medical equipment.
RUSSIA
The Russian medical market is potentially huge, given its population and potential wealth of natural resources. Health expenditure remains low however, and patients are often forced to rely on out-of-pocket payments for treatment. A system of medical insurance is in place, but it is badly managed and the quality of treatment varies from region to region. The Russian healthcare system retains many of its Soviet-era characteristics, remaining bureaucratic and inefficient. However, the government’s national ‘health’ project aims to improve healthcare standards. Since the project’s implementation, numerous medical facilities have been upgraded and a substantial number of medical personnel have been awarded salary increases. In 2011, the Russian market for medical equipment and supplies is estimated at US$5,961.3 million. Per capita spending is low by European standards at US$42 per capita. This is despite rapid growth, especially of imported products, in the 2006-08 period.
11 Key Markets Covered
Bulgaria
Croatia
Czech Republic
Hungary
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Ukraine
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=53537.
Contact sales@reportsandreports.com for further information.
Central & Eastern Europe is composed of a diverse range of markets, all at different stages of development. Markets throughout the region grew very rapidly until 2008, as many countries joined the EU between 2004 and 2007. All have healthcare systems in great need of renovation and updating, and spending on new diagnostic equipment in particular has been very strong. Most new equipment is imported, as Russia, Poland, the Czech Republic, Ukraine and Hungary represent the five largest markets in the region. Slovenia is a small market, but has the highest per capita expenditure, on a par with much of Western Europe.
The Economic Situation
All countries in the CEE region were affected by the global economic crisis to some extent; Ukraine was particularly hard hit with its economy contracting by 14.8% in 2009. However, most of the region emerged from recession in 2010 and all CEE countries were exhibiting positive growth rates by 2011. The regional economy is expected to grow by an annual average of 3.1% between 2012 and 2016, although the ongoing eurozone crisis may negatively impact this rate. The CEE region contains export-dependent countries such as the Czech Republic and Hungary, which will be vulnerable to any depressed demand in the eurozone. However, financial assistance provided by the IMF has helped countries such as Romania to strengthen their economies and limit the effects of the recession on the health sector; overall demand for medical devices has therefore remained strong, particularly in the consumables field.
Regional Health Expenditure
Total health expenditure for the CEE region is projected to reach an estimated US$329.0 billion by 2016, equal to 6.7% of GDP. At present, only 29% of spending in the region is private, but over 85% of this is composed of out-of-pocket payments. The area of private healthcare plans remains largely undeveloped within most markets. Slovenia, the wealthiest country per capita in the region, is the only state in which private plans have become a strong feature, representing almost half of total private spending.
Focus on market opportunities: Diagnostic Imaging
The table below shows the rise in demand for imported diagnostic imaging equipment since the end of the economic crisis, following a period of slow-moderate growth. Between 2006 and 2010, the CAGR for such equipment did not exceed 20% in the countries listed below; however, import performance was much more encouraging in the year ending October 2011, particularly in Romania and Poland where growth rates reached 47.8% and 34.0%, respectively. Only modest growth was observed in the Czech Republic and Slovakia, however. It will take time for countries such as Ukraine to return to pre-crisis growth rates; renewed investment in high-tech equipment will ensue as their economies strengthen.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=53537.
Highlights from the region
CZECH REPUBLIC
The Czech Republic was one of the larger and richer former Soviet countries to join the EU in May 2004. Its regulation and trade rules are now generally aligned to EU standards. It is well-located in central Europe and has an estimated population of 10.5 million in 2011. Healthcare funding is largely public, and mainly through health insurance. Private spending only accounts for an estimated 16.6% of total health expenditure in 2011. Provision of care is also largely public; the Czech Republic has yet to develop a substantial private sector. Around 80% of the Czech Republic medical device market is supplied by imports, which have risen rapidly in the past decade. In 2011, 35.7% were sourced from Germany. Other major suppliers were the Netherlands, Belgium, Switzerland and France. In 2011, imports rose by 6.6% over 2010 and by a 2007-2011 CAGR of 8.2%.
HUNGARY
In 2011, the Hungarian market for medical equipment and supplies is estimated at US$573 million, or US$58 per capita. The market value has stalled since 2008, but it is expected that it will bounce back to expand at a CAGR of 4.5% per annum in the 2011-16 period, reaching US$715 million by 2016, equal to US$73 per capita.
Around 84% of the medical device market is supplied by imports. Most are sourced from the European Union, principally the Netherlands and Germany. There is a sizeable domestic production sector, with X-ray apparatus as a particular historic specialty, but this is largely geared towards export markets.
POLAND
The size of the private healthcare sector is slowly expanding. The availability of private facilities improved significantly in 2000, when bed numbers increased three-fold. Around a quarter of health expenditure is private, although out-of-pocket payments account for most of this. In 2011, the Polish market for medical equipment and supplies is estimated at US$2,013.4 million, or US$53 per capita. The market experienced rapid growth until the end of 2008, but imports fell back sharply in the early part of 2009. The economic downturn has so far proved short, however, with growth resuming in 2010, albeit at a slightly lower rate than in previous years. Around 85% of the Polish medical device market is supplied by imports. Germany and the Netherlands were the leading suppliers in 2011, together accounting for around nearly half of imports. Germany was the leading supplier of most categories of medical equipment.
RUSSIA
The Russian medical market is potentially huge, given its population and potential wealth of natural resources. Health expenditure remains low however, and patients are often forced to rely on out-of-pocket payments for treatment. A system of medical insurance is in place, but it is badly managed and the quality of treatment varies from region to region. The Russian healthcare system retains many of its Soviet-era characteristics, remaining bureaucratic and inefficient. However, the government’s national ‘health’ project aims to improve healthcare standards. Since the project’s implementation, numerous medical facilities have been upgraded and a substantial number of medical personnel have been awarded salary increases. In 2011, the Russian market for medical equipment and supplies is estimated at US$5,961.3 million. Per capita spending is low by European standards at US$42 per capita. This is despite rapid growth, especially of imported products, in the 2006-08 period.
11 Key Markets Covered
Bulgaria
Croatia
Czech Republic
Hungary
Poland
Romania
Russia
Serbia
Slovakia
Slovenia
Ukraine
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=53537.
Contact sales@reportsandreports.com for further information.
U.S. Pet Supplements and Nutraceutical Treats Market - 4th Edition
ReportsnReports add new market research report "Pet Supplements and
Nutraceutical Treats in the U.S." to its vast collection.
Following double-digit annual sales gains in years past, sales growth in the U.S. market for pet supplements and nutraceutical treats has begun to moderate: marketers will need to work harder to remain relevant. With hundreds of products batting for limited shelf space, selling pet supplements means educating consumers and retailers about their benefits and differences, with veterinarians remaining the toughest customers of all. Clinical testing, proprietary formulas, the NASC (National Animal Supplement Council) seal of approval, novel ingredients, natural ingredients, retail merchandising, and social media programs are all parts of the competitive equation as, now more than ever, the sale of one pet supplement or nutraceutical treat comes at the expense of another.
Throughout the recession and its aftermath of economic doldrums, sales of dog and cat treats remained strong. So it is perhaps not surprising that pet supplements are increasingly resembling treats. Traditional forms still abound, including tablets and pills. But palatability concerns and the human/pet “enjoyment factor” of supplements in treat form has led to an explosion of functional biscuits and “soft chews.” Also gaining ground are alternative delivery formats including gels and pastes, as well as gravies and powders designed to be added to pet food. As a result, the boundary between supplements and foods continues to blur as the number of pet owners regularly supplementing their pet’s diet in one way or another continues to rise.
As in human supplements, aging is the core market driver as more pets suffer from age-related conditions such as joint deterioration and cognitive dysfunction. Also taking a page from human supplements are popular ingredients including glucosamine, omega fatty acids, and probiotics, along with trendier ingredients like bee pollen, green tea, and elk velvet antler. At the same time, many supplements not sold as foods continue to inhabit a regulatory gray area while banking on “unapproved drugs for which enforcement discretion may be exercised” status with the FDA. Nevertheless, the industry’s self-policing efforts, spearheaded by the NASC, have clearly raised the industry confidence level, as has the increased focus on supplements wielding the kinds of scientific backing most veterinarians require.
This 4th edition of Packaged Facts’ definitive Pet Supplements and Nutraceutical Treats in the U.S. report segments the market into two categories—pet supplements and nutraceutical treats (i.e., those containing supplements or novel botanical ingredients addressing specific health conditions)—with a primary focus on products for dogs and cats, but also extending to horses and other types of small companion animals. The report provides a forward-looking examination of the market from every angle, including an update on the regulatory situation; historical sales figures and projections spanning the 2008-2017 period; breakouts by supplement type and retail channel; competitive activity by channel including pet specialty, veterinary, mass-market, and online; marketing and new product trends; and consumer patterns and preferences.
With market projections placing U.S. retail sales at $1.6 billion by 2017, the report homes in on high-growth segments including feline, alternative administration formats including chewable tablets or soft chews, gels, pastes, liquids, powders, sprays, and pet food toppers, as well as full-fledged nutraceutical treats, natural and organic products, senior and other condition-specific products, featured ingredients, and enthusiastic or potential consumer demographics. Featuring exclusive Packaged Facts pet owner survey data, the report details consumer trends in dog and cat supplement and nutraceuticals treat usage by product type, brand, and retail channel.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218313.
Table of Contents
Chapter 1: Executive Summary
Scope & Methodology
Market Definition
Two Product Categories
Two Animal Classifications
Report Methodology
Market Trends
U.S. Retail Sales Chart Gradual Recovery Post Recession
Figure 1-1: Share of U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Small Animal (Dog, Cat, Other) vs. Equine, 2008 vs. 2012 (percent)
Share of Pet Supplement and Nutraceutical Treat Sales by Function
Sales by Distribution Channel
Annual Sales Gains Expected to Rise Gradually
Figure 1-2: U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat, Other),Equine, 2008, 2012, 2017 (in millions of dollars)
Figure 1-3: Pet Supplement Opportunity Gap: Percentage of Dog or Cat Owners Who Use Human Supplements vs. Percentage of Dog or Cat Owners Who Buy Pet Supplements, 2012
Competitive Trends
Most Supplement Companies Focused in Pet Health
Veterinary Channel Marketers and Trends
Channel Cross-Over and Expansion
Private-Label Supplement Range Expanding
Marketing and New Product Trends
Advertising and Promotion
Beyond Print
Educating Retailers
New Product Activity Continues, Though at Slower Pace
Focus on Felines
Illustration 1-1: Trade Ad for NaturVet’s Functional Soft Chews for Cats (Pet Business, January 2013)
Consumer Trends
Overview of Supplemental Pet Nutrition Products
Table 1-1: Use of Supplemental Pet Nutrition Products by Type: Dog vs. Cat Owners, 2012 (percent)
Topline Usage Rates Among Dog and Cat Owners
Figure 1-4: Use of Pet Supplements: Dog vs. Cat Owners,2010 vs. 2012 (percent)
Figure 1-5: Use of Pet Nutraceutical Treats: Dog vs. Cat Owners, 2012 (percent)
Usage of Dog Products Recovers in 2011 and 2012
Multiple-Pet Factor Favors Dog Supplement/Nutraceutical Treat Sales
Chapter 2: Introduction
Product Parameters
Market Definition
Two Product Categories
Two Animal Classifications
Report Methodology
Condition-Specific Products
Natural vs. Synthetic
Organic Regulation
Third-Party Organic Accreditation
Product Regulation
Two Choices: Food or Drug
The National Animal Supplement Council
Product Labeling and Claims
Scientific Advisory Committee
Adverse Event Reporting
NASC Implements New Rules
NASC Honored for Efforts on Behalf of Industry
Human Supplement Regulation Based on Dietary Supplement
Health and Education Act (DSHEA)
Chapter 3: The Market
Market Size and Composition
U.S. Retail Sales Chart Gradual Recovery Post Recession
Table 3-1: U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat, Other),Equine, 2008–2012 (in millions of dollars)
Figure 3-1: Share of U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Small Animal (Dog, Cat, Other) vs. Equine, 2008 vs. 2012 (percent)
Small Animal Supplements and Nutraceutical Treats
Table 3-2: U.S. Retail Sales of Small Animal (Dog, Cat, Other)Pet Supplements and Nutraceutical Treats: Total,Supplements, Treats, 2008–2012 (in millions of dollars)
Figure 3-2: Share of U.S. Retail Sales of Small Animal (Dog, Cat, Other) Pet Supplements and Nutraceutical Treats: Supplements vs. Treats, 2008 vs. 2012 (percent)
Figure 3-3: Share of U.S. Retail Sales of Small Animal Pet Supplements and Nutraceutical Treats by Animal Type:Dog, Cat, Other, 2012 (percent)
Equine Supplements and Nutraceutical Treats
Table 3-3: U.S. Retail Sales of Equine Supplements and Nutraceutical Treats: Total, Supplements, Treats, 2008–2012 (in millions of dollars)
Figure 3-4: Share of U.S. Retail Sales of Equine Supplements and Nutraceutical Treats: Supplements vs. Treats, 2008 vs. 2012 (percent)
Mass-Market Sales and Composition
Table 3-4: SymphonyIRI-Tracked Sales of Dog and Cat Nutraceutical Treats and Supplements, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Figure 3-5: Share of SymphonyIRI-Tracked Sales of Dog and Cat Nutraceutical Treats and Supplements, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Natural/Organic Product Share of Sales
Figure 3-6: Natural/Organic Share of U.S. Retail Sales of Pet
Supplements and Nutraceutical Treats, 2008, 2010, 2012(percent)
Pet Supplement Sales Up 7% in Natural Supermarket Channel
Table 3-5: Retail Dollar Sales of Pet Products in the Natural Supermarket Channel by Category and Segment, 2011 vs.2012 (in millions of dollars)
Share of Pet Supplement and Nutraceutical Treat Sales by Function
Figure 3-7: Share of U.S. Retail Sales of Dog Supplements and Nutraceutical Treats by Type: 2012 (percent)
Figure 3-8: Share of U.S. Retail Sales of Cat Supplements and Nutraceutical Treats by Type: 2012 (percent)
Figure 3-9: Share of U.S. Retail Sales of Horse Supplements and Nutraceutical Treats by Type, 2012 (percent)
Horse Supplement Usage by Form and Region
Table 3-6: Form of Horse Supplements Usually Used, 2006, 2008, 2010 (percent)
Sales by Distribution Channel
Figure 3-10: Share of U.S. Retail Sales of Small Animal Supplements and Nutraceutical Treats by Distribution Channel, 2010 vs. 2012 (percent)
Figure 3-11: Share of U.S. Retail Sales of Equine Supplements and Nutraceutical Treats by Distribution Channel, 2012 (percent)
Pet Supplements Less Than 5% of Pet Specialty Store Sales
Regardless of Animal Category
Figure 3-12: Supplement Share of Pet Specialty Store Sales
by Animal Category: 2011 (percent)
Table 3-7: Percentage of Pet Specialty Store Sales Volume
Derived from Pet Supplements by Animal Type, 2011
Market Outlook
Positive Trends in Human Supplements Bode Well for Pet Supplements
Pets as Family Trend Bolsters Pet Health/Wellness Spending
Table 3-8: Pet Owner Attitudes and Behavior Characterizing Human/Animal Bond, 2012 (percent)
Table 3-9: Level of Veterinary Expenditures by Human-Animal Bond and Animal Type, 2011 (mean dollar per household)
Figure 3-13: Level of Agreement with Statement: “I buy pet supplements and/or functional treats to make doubly sure that my pet gets all the special nutrition it needs,” 2012(percent)
A Natural Advantage
Figure 3-14: U.S. Retail Sales of Natural Pet Products, 2008, 2012, 2017 (in millions of dollars)
Figure 3-15: Level of Agreement with Statement: “If natural/organic pet products were more available where I shop, I would buy them more often,” 2012 (percent)
Figure 3-16: Level of Agreement with Statement: “I am veryconcerned about the safety of the pet products I buy,” 2012(percent)
Figure 3-17: Level of Agreement with Statement: “I prefer tobuy pet supplements and/or functional treats that are allnaturalor organic,” 2012 (percent)
Pet Med Alternatives
Table 3-10: Level of Agreement with Statement: “I avoid usingpet medications as much as possible”: Dog Owners vs. Cat Owners, 2011 (percent)
Table 3-11: Level of Agreement with Statement: “I prefer to try holistic/natural pet treatments including nutritional supplements before resorting to pet medications”: Dog Owners vs. Cat Owners, 2011 (percent)
Supplements Advancing Among Veterinarians, But They Still Want More Testing
Negative PR
Growing Focus on Therapeutic Pet Foods
Table 3-12: Level of Agreement with Statement: “I believe that pet supplements are more effective than ‘functional’ pet food designed to treat specific health conditions,” 2012 (percent)
Table 3-13: Level of Agreement with Statement: “I believe “functional” pet food designed to treat specific health conditions is more effective than supplements in pill, tablet, liquid, or powder form,” 2012 (percent)
Table 3-14: Level of Agreement with Statement: “I do not use pet supplements because I believe my pet gets all the nutrients it needs from the pet food I buy,” 2012 (percent)
Illustration 3-1: Hill’s Everypeteverytime.com Vet-Targeted Website
Nutraceutical Treats Expanding Market Boundaries
Lack of Product Understanding Hinders Market
Figure 3-18: Level of Agreement with Statement: “I believe that ordinary pet food provides all the nutrition that pets need,” 2012 (percent)
Equine Segment Suffers from Decline in Horse Population
Table 3-15: How Pet Owners View Their Pets by Type of Pet, 2011 (percent)
Regulatory Situation: Status Quo Seems to Working
Pet Market Macrotrends
Pet Ownership and Population Trends
Table 3-16: Household Penetration Rates for Dogs and Cats, 2007-2012 (U.S. households—percent and number in thousands)
The Aging Pet Population
Table 3-17: Age of Dogs and Cats, 2012 (percent of pet owners)
Pet Overweight and Obesity
Table 3-18: Percentage and Number of Overweight and Obese Dogs and Cats, 2011
Figure 3-19: “My pet would be considered overweight or obese,” 2012 (percent)
Pet Owners Still Budget Crunching Post Recession
Table 3-19: Level of Agreement with Statement: “I am spending less on pet products because of the economy,”2010-2012 (percent)
Looking Ahead
Annual Sales Gains Expected to Rise Gradually
Table 3-20: Projected U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat,
Other), Equine, 2012–2017 (in millions of dollars)
Table 3-21: Projected U.S. Retail Sales of Small Animal (Dog, Cat, Other) Pet Supplements and Nutraceutical Treats:
Total, Supplements, Treats, 2012–2017 (in millions of dollars)
Table 3-22: Projected U.S. Retail Sales of Equine
Supplements and Nutraceutical Treats: Total, Supplements,
Treats, 2012–2017 (in millions of dollars)
Table 3-23: Share of U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Small Animal (Dog, Cat, Other) vs. Equine, 2012–2017 (percent)
Why the Sluggishness?
On a Positive Note
Illustration 3-2: GNC Vitamins & Supplement for Cats Center in PetSmart
Illustration 3-3: GNC Vitamins & Supplement for Cats Center in PetSmart (Closeup)
Figure 3-20: Level of Agreement with Statement: “I would prefer to buy pet supplements under the same human brand names I’m familiar with (such as One-a-Day),” 2012 (percent)
Illustration 3-4: Royal Canin’s New X-Small Dog Pet Food Line
Illustration 3-5: Iams’ New Senior Plus (Age 11+) Pet Foods
Figure 3-21: Pet Supplement Opportunity Gap: Percentage of
Dog or Cat Owners Who Use Human Supplements vs.
Percentage of Dog or Cat Owners Who Buy Pet Supplements, 2012
Chapter 4: Competitive Trends
Most Supplement Companies Focused in Pet Health
Mergers & Acquisitions
Bayer Acquires Teva Animal Health
Perrigo Acquires Sergeant’s
Kemin Acquires Genesis
Unicharm Takes Stake in Hartz (Sumitomo)
Nutri-Vet Acquired by Imperial Capital/Petra Pet
The Honest Kitchen Receives Capital Investments
Quaker Pet Group Acquires Watson’s Senior Pet Supplies
Pet Specialty Channel Marketers
Mass-Market Activity in Pet Supplements: Leading Marketers and Brands
Mass-Market Activity in Nutraceutical Treats: Leading
Marketers and Brands
Table 4-1: SymphonyIRI-Tracked Sales of Pet Supplements, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Table 4-2: SymphonyIRI-Tracked Sales of Nutraceutical Dog Treats, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Table 4-3: SymphonyIRI-Tracked Sales of Nutraceutical Cat Treats, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Veterinary Channel Marketers and Trends
Patented Formulations
Clinically Proven
Illustration 4-1: GLC Direct’s New Actistatin Joint Supplement
Teva Bounces Back with New Parent and New Products
Illustration 4-2: Teva Animal Health Products Web Page
The French Contingent: Sogeval, Vétoquinol, Virbac
Illustration 4-3: Virbac’s Pet-Tabs Home Page
Channel Cross-Over and Expansion
Illustration 4-4: Tomlyn Pet Supplements and Soft Chews
Illustration 4-5: Nutramax’s New Line of Supplements for Walmart
Illustration 4-6: Nutri-Vet’s Best Pet Health Supplements for the Mass Market
Iams and Merrick Back Out of Pure-Play Supplement Waters, Nestlé Purina Forges Ahead
Illustration 4-7: Nestlé Purina’s FortiFlora Supplement Web Page
Illustration 4-8: Fruitables Canned Supplements for Dogs & Cats
Illustration 4-9: Nature’s Variety Raw Daily Boost Powder Supplements
Novus Ramping Up in Companion Animal Supplements
Illustration 4-10: Promotional Flyer for Novus’s Arenus Supplements
Illustration 4-11: Trade Ad for Novus’s Previda Probiotic Ingredient (Petfood Industry, December 2012)
Private-Label Supplement Range Expanding
Illustration 4-12: Selected PetSmart/GNC Specialty Supplements
Illustration 4-13: GNC Vitamins & Supplement for Dogs Center in PetSmart
Illustration 4-14: Banner Ad for GNC Pets Line on PetSmart.com
Figure 4-1: Level of Agreement with Statement: “I buy pet supplements under the same human supplement brand names I’m familiar with (such as GNC),” 2012 (percent)
Illustration 4-15: Petco’s Pet Supplement Web Page
Illustration 4-16: Petco’s Healthy Select Store-Brand Pet Supplements
Illustration 4-17: Petco Store-Brand Pet Supplements
Illustration 4-18: “Supplement” Results from Butler Schein’s Online Compendium
Table 4-4: Selected Marketers and Brands of Pet Supplements and Nutraceutical Treats, 2012
Chapter 5: Marketing and New Product Trends
Marketing Trends
Advertising and Promotion
Illustration 5-1: Trade Ad for GreenDog Naturals Pet Supplements (Pet Age, October 2011)
Clinically Proven
Illustration 5-2: Trade Ad for ProLabs’ Flex Rx (Pet Business, April 2012)
Nutramax Relies on Celebrities, Including The Lord
Illustration 5-3: Nutramax Videos on YouTube
Nutri-Vet Deploys Award-Winning Animated Videos
Illustration 5-4: Nutri-Vet Animated Videos on YouTube
Vétoquinol Introduces Rewards Program for Veterinarians
Educating Retailers
Table 5-1: Repeat, Impulse, Sale/Promoted, and Comparison-Shopping-Based Purchasing Rates for Pet Supplements vs. Other Types of Nonfood Pet Products, 2012 (percent)
Merchandising
Illustration 5-5: Retail Displays of Tomlyn Supplements and Treats
On the Web
Illustration 5-6: GNC Pet Supplements at GNC.com
Illustration 5-7: Website Banner Link to Online Shopping Options
New Product Trends
Activity Continues, Though at Somewhat Slower Pace
Focus on Felines
Illustration 5-8: Trade Ad for NaturVet’s Condition-Specific Soft Chews for Cats (Pet Business, January 2013)
Illustration 5-9: Mars/Nutro’s Feline Greenies Smartbites Treats Soft Chews, Gels, Pastes, and Other Non-Traditional Forms
Illustration 5-10: NoviPet’s Soft Chew Supplements for Dogs
Illustration 5-11: Trade Ad for Tomlyn’s Gel Supplements for Cats
Illustration 5-12: Synergy Laboratories’ Richard’s Organics 100% Natural Nutrient Pastes
Pet Food Add-Ins
Illustration 5-13: Bergan’s Prudence–Nature’s Wellness Supplement Powders
Illustration 5-14: Trade Ad for The Missing Link Supplement Powders (Pet Age, December, 2012)
Liquid Supplements
Illustration 5-15: Animal Business Concepts’ Cool Pet Hydration Formulas
Condition-Specific Supplements
Illustration 5-16: PetSmart/GNC Nutraceutical Dog Treats
Illustration 5-17: Oxbow Animal Health’s Natural Science
Small Animal Supplements
Joint Support
Illustration 5-18: Steadfast Joint Health Supplement from Arenus (Novus)
Illustration 5-19: Trade Ad for Grizzly Pet Products’ Joint Aid 4 Dogs (Pet Business, December 2012)
Skin & Coat Health
Illustration 5-20: Cardinal Lab’s Full Life Omega Antioxidant Treats
Illustration 5-21: In Clover’s Glow Skin & Coat Soft Chews for Dogs
Illustration 5-22: Vitakraft’s Sunseed Mineral Treats
Calming/Behavior-Control Products
Digestive Health, Immune Support, and Probiotics
Illustration 5-23: Trade Ad for Herbsmith’s Microflora Plus for Digestion for Dogs and Cats (Pet Business, February 2012)
Illustration 5-24: DogGestive Digestive Health Supplement for Dogs
Illustration 5-25: GeneFlora for Pets (and People) Probiotic Supplements
Illustration 5-26: Harrison's Bird Foods’ Avian Enzyme Oral Care/Breath Products
Illustration 5-27: Vetri-Science’s Perio-Support
Weight Loss/Maintenance
Illustration 5-28: Garmon Corp.’s Slim-N-Fit Weight Control Canine Supplement
Liver, Kidney, and Bladder Function
Illustration 5-29: Sogeval’s S-Adenoysl-225 Snap Tablets
Illustration 5-30: Trade Ad for Herbsmith’s Bladder Care Supplements (Pet Business, April 2012)
Senior-Specific
Illustration 5-31: Quaker Pet Group’s Silver Tails Collection of Senior Pet Products
Illustration 5-32: AvidLife Pets’ Nutritional and Lubricant Eye Drops
Multivitamins, Multitasking, and Multipet
Illustration 5-33: Harrisons’ Pet Products’ Sunshine Factor and Booster Supplements
Featured Ingredients Bee Pollen and Bee Propolis
Illustration 5-34: Trade Ad for Ferrera Farms Naturals Bee the Best Supplements (Pet Business, April 2012)
Elk Antler
Illustration 5-35: Trade Ad for Wapiti Laboratories’ Elk Velvet Antler Supplements (Pet Product News International 2013 Annual Buying Guide)
Flax
Green Tea
Illustration 5-36: Consumer Ad for Reishi with Green Tea Immunity Boost Canine Supplement (Animal Wellness,June/July 2012)
Green-Lipped Mussel
Illustration 5-37: Greenies JointCare Treats with Green-Lipped Mussel
Kelp
Mushrooms
Illustration 5-38: Mushroom Matrix’s Equine Matrix and Pet Matrix
Chapter 6: Consumer Trends
Overview of Supplemental Pet Nutrition Products
Table 6-1: Use of Supplemental Pet Nutrition Products by Type: Dog vs. Cat Owners, 2012 (percent)
Consumer Focus: Pet Supplements
Topline Usage Rates Among Dog and Cat Owners
Figure 6-1: Use of Pet Supplements: Dog vs. Cat Owners,2010 vs. 2012 (percent)
Topline Number of Product Purchasers
Over Two-Thirds Use OTC Products
Figure 6-2: Use of OTC Pet Supplements: Dog Owners vs. Cat Owners, 2012 (percent)
Figure 6-3: Use of Vet-Prescribed or Vet-Dispensed Pet Supplements: Dog vs. Cat Owners, 2012 (percent)
Over Half Buy at Pet Superstores
Table 6-2: Purchasing Patterns for Pet Supplements by Retail Channel, 2010 vs. 2012 (percent of U.S. dog or cat owners who use OTC pet supplements)
Petco and Hartz Tied as Top Brands by Usage Rates
Table 6-3: Purchasing Patterns for Pet Supplements by Brand, 2012 (percent of U.S. dog or cat owners who use pet supplements)
Consumer Traits of Pet Supplement Purchasers
Table 6-4a: Use of Pet Supplements by Consumer Trait: Dog Owners, 2012 (percent)
Table 6-4b: Use of Pet Supplements by Consumer Trait: Cat Owners, 2012 (percent)
Joint Health Divides Dog from Cat Segments
Table 6-5: Use of Pet Supplements and Nutraceutical Treats by Type: Dog vs. Cat Owners, 2012 (percent of U.S. dog or cat owners who use pet nutraceutical treats)
Consumer Focus: Nutraceutical Treats
Topline Usage Rates Among Dog and Cat Owners
Figure 6-4: Use of Pet Nutraceutical Treats: Dog vs. Cat Owners, 2012 (percent)
Topline Number of Product Purchasers
Purchasing Patterns: Pet Superstores vs. Walmart
Table 6-6: Purchasing Patterns for Nutraceutical Treats by Retail Channel, 2012 (percent of U.S. dog or cat owners who use OTC pet supplements)
Few Nutraceutical Treats Show up in Experian Simmons Data
Consumer Traits of Pet Nutraceutical Treat Purchasers
Table 6-7a: Use of Pet Nutraceutical Treats by Consumer Trait: Dog Owners, 2012 (percent)
Table 6-7b: Use of Pet Nutraceutical Treats by Consumer Trait: Cat Owners, 2012 (percent)
Historical Usage Rate Trends
Usage of Dog Products Recovers in 2011 and 2012
Figure 6-5: Purchasing Rates for Supplemental Pet Nutrition Products: Dog vs. Cat Owners, Summer 2012 (U.S. dog- or cat-owning households)
Table 6-8: Purchasing Rates for Supplemental Pet Nutrition
Products: Dog vs. Cat Owners, Spring 2005-Spring 2011 (U.S. dog- or cat-owning households)
Usage Rates for Cat Products Hit Bump in the Climb
Table 6-9: Household Income Level Snapshot: Dog vs. Cat Owners, 2012 (U.S. dog- or cat-owning households)
Product Purchaser Demographics
Multiple-Pet Factor Favors Dog Supplement/Nutraceutical
Treat Sales
Table 6-10: Purchasing Rates for Supplemental Pet Nutrition Products by Number of Pets: Dog vs. Cat Owners, 2012 (percent and index for U.S. dog- or cat-owning households)
Table 6-11a: Dog and Cat Ownership Trends by Number of Pets, 2008-2012 (percent of U.S. households)
Table 6-11b: Dog and Cat Ownership Trends by Number of Pets, 2008-2012 (number of U.S. households in thousands)
Demographic Patterns Are Anomalous
Table 6-12: Demographics for Purchasing of Supplemental Pet
Nutrition Products: Dog Owners, 2012 (percent, number of households, and index)
Table 6-13: Demographics for Purchasing of Supplemental Pet Nutrition Products: Cat Owners, 2012 (percent, number of households, and index)
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218313.
Contact sales@reportsandreports.com for further information.
Following double-digit annual sales gains in years past, sales growth in the U.S. market for pet supplements and nutraceutical treats has begun to moderate: marketers will need to work harder to remain relevant. With hundreds of products batting for limited shelf space, selling pet supplements means educating consumers and retailers about their benefits and differences, with veterinarians remaining the toughest customers of all. Clinical testing, proprietary formulas, the NASC (National Animal Supplement Council) seal of approval, novel ingredients, natural ingredients, retail merchandising, and social media programs are all parts of the competitive equation as, now more than ever, the sale of one pet supplement or nutraceutical treat comes at the expense of another.
Throughout the recession and its aftermath of economic doldrums, sales of dog and cat treats remained strong. So it is perhaps not surprising that pet supplements are increasingly resembling treats. Traditional forms still abound, including tablets and pills. But palatability concerns and the human/pet “enjoyment factor” of supplements in treat form has led to an explosion of functional biscuits and “soft chews.” Also gaining ground are alternative delivery formats including gels and pastes, as well as gravies and powders designed to be added to pet food. As a result, the boundary between supplements and foods continues to blur as the number of pet owners regularly supplementing their pet’s diet in one way or another continues to rise.
As in human supplements, aging is the core market driver as more pets suffer from age-related conditions such as joint deterioration and cognitive dysfunction. Also taking a page from human supplements are popular ingredients including glucosamine, omega fatty acids, and probiotics, along with trendier ingredients like bee pollen, green tea, and elk velvet antler. At the same time, many supplements not sold as foods continue to inhabit a regulatory gray area while banking on “unapproved drugs for which enforcement discretion may be exercised” status with the FDA. Nevertheless, the industry’s self-policing efforts, spearheaded by the NASC, have clearly raised the industry confidence level, as has the increased focus on supplements wielding the kinds of scientific backing most veterinarians require.
This 4th edition of Packaged Facts’ definitive Pet Supplements and Nutraceutical Treats in the U.S. report segments the market into two categories—pet supplements and nutraceutical treats (i.e., those containing supplements or novel botanical ingredients addressing specific health conditions)—with a primary focus on products for dogs and cats, but also extending to horses and other types of small companion animals. The report provides a forward-looking examination of the market from every angle, including an update on the regulatory situation; historical sales figures and projections spanning the 2008-2017 period; breakouts by supplement type and retail channel; competitive activity by channel including pet specialty, veterinary, mass-market, and online; marketing and new product trends; and consumer patterns and preferences.
With market projections placing U.S. retail sales at $1.6 billion by 2017, the report homes in on high-growth segments including feline, alternative administration formats including chewable tablets or soft chews, gels, pastes, liquids, powders, sprays, and pet food toppers, as well as full-fledged nutraceutical treats, natural and organic products, senior and other condition-specific products, featured ingredients, and enthusiastic or potential consumer demographics. Featuring exclusive Packaged Facts pet owner survey data, the report details consumer trends in dog and cat supplement and nutraceuticals treat usage by product type, brand, and retail channel.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218313.
Table of Contents
Chapter 1: Executive Summary
Scope & Methodology
Market Definition
Two Product Categories
Two Animal Classifications
Report Methodology
Market Trends
U.S. Retail Sales Chart Gradual Recovery Post Recession
Figure 1-1: Share of U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Small Animal (Dog, Cat, Other) vs. Equine, 2008 vs. 2012 (percent)
Share of Pet Supplement and Nutraceutical Treat Sales by Function
Sales by Distribution Channel
Annual Sales Gains Expected to Rise Gradually
Figure 1-2: U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat, Other),Equine, 2008, 2012, 2017 (in millions of dollars)
Figure 1-3: Pet Supplement Opportunity Gap: Percentage of Dog or Cat Owners Who Use Human Supplements vs. Percentage of Dog or Cat Owners Who Buy Pet Supplements, 2012
Competitive Trends
Most Supplement Companies Focused in Pet Health
Veterinary Channel Marketers and Trends
Channel Cross-Over and Expansion
Private-Label Supplement Range Expanding
Marketing and New Product Trends
Advertising and Promotion
Beyond Print
Educating Retailers
New Product Activity Continues, Though at Slower Pace
Focus on Felines
Illustration 1-1: Trade Ad for NaturVet’s Functional Soft Chews for Cats (Pet Business, January 2013)
Consumer Trends
Overview of Supplemental Pet Nutrition Products
Table 1-1: Use of Supplemental Pet Nutrition Products by Type: Dog vs. Cat Owners, 2012 (percent)
Topline Usage Rates Among Dog and Cat Owners
Figure 1-4: Use of Pet Supplements: Dog vs. Cat Owners,2010 vs. 2012 (percent)
Figure 1-5: Use of Pet Nutraceutical Treats: Dog vs. Cat Owners, 2012 (percent)
Usage of Dog Products Recovers in 2011 and 2012
Multiple-Pet Factor Favors Dog Supplement/Nutraceutical Treat Sales
Chapter 2: Introduction
Product Parameters
Market Definition
Two Product Categories
Two Animal Classifications
Report Methodology
Condition-Specific Products
Natural vs. Synthetic
Organic Regulation
Third-Party Organic Accreditation
Product Regulation
Two Choices: Food or Drug
The National Animal Supplement Council
Product Labeling and Claims
Scientific Advisory Committee
Adverse Event Reporting
NASC Implements New Rules
NASC Honored for Efforts on Behalf of Industry
Human Supplement Regulation Based on Dietary Supplement
Health and Education Act (DSHEA)
Chapter 3: The Market
Market Size and Composition
U.S. Retail Sales Chart Gradual Recovery Post Recession
Table 3-1: U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat, Other),Equine, 2008–2012 (in millions of dollars)
Figure 3-1: Share of U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Small Animal (Dog, Cat, Other) vs. Equine, 2008 vs. 2012 (percent)
Small Animal Supplements and Nutraceutical Treats
Table 3-2: U.S. Retail Sales of Small Animal (Dog, Cat, Other)Pet Supplements and Nutraceutical Treats: Total,Supplements, Treats, 2008–2012 (in millions of dollars)
Figure 3-2: Share of U.S. Retail Sales of Small Animal (Dog, Cat, Other) Pet Supplements and Nutraceutical Treats: Supplements vs. Treats, 2008 vs. 2012 (percent)
Figure 3-3: Share of U.S. Retail Sales of Small Animal Pet Supplements and Nutraceutical Treats by Animal Type:Dog, Cat, Other, 2012 (percent)
Equine Supplements and Nutraceutical Treats
Table 3-3: U.S. Retail Sales of Equine Supplements and Nutraceutical Treats: Total, Supplements, Treats, 2008–2012 (in millions of dollars)
Figure 3-4: Share of U.S. Retail Sales of Equine Supplements and Nutraceutical Treats: Supplements vs. Treats, 2008 vs. 2012 (percent)
Mass-Market Sales and Composition
Table 3-4: SymphonyIRI-Tracked Sales of Dog and Cat Nutraceutical Treats and Supplements, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Figure 3-5: Share of SymphonyIRI-Tracked Sales of Dog and Cat Nutraceutical Treats and Supplements, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Natural/Organic Product Share of Sales
Figure 3-6: Natural/Organic Share of U.S. Retail Sales of Pet
Supplements and Nutraceutical Treats, 2008, 2010, 2012(percent)
Pet Supplement Sales Up 7% in Natural Supermarket Channel
Table 3-5: Retail Dollar Sales of Pet Products in the Natural Supermarket Channel by Category and Segment, 2011 vs.2012 (in millions of dollars)
Share of Pet Supplement and Nutraceutical Treat Sales by Function
Figure 3-7: Share of U.S. Retail Sales of Dog Supplements and Nutraceutical Treats by Type: 2012 (percent)
Figure 3-8: Share of U.S. Retail Sales of Cat Supplements and Nutraceutical Treats by Type: 2012 (percent)
Figure 3-9: Share of U.S. Retail Sales of Horse Supplements and Nutraceutical Treats by Type, 2012 (percent)
Horse Supplement Usage by Form and Region
Table 3-6: Form of Horse Supplements Usually Used, 2006, 2008, 2010 (percent)
Sales by Distribution Channel
Figure 3-10: Share of U.S. Retail Sales of Small Animal Supplements and Nutraceutical Treats by Distribution Channel, 2010 vs. 2012 (percent)
Figure 3-11: Share of U.S. Retail Sales of Equine Supplements and Nutraceutical Treats by Distribution Channel, 2012 (percent)
Pet Supplements Less Than 5% of Pet Specialty Store Sales
Regardless of Animal Category
Figure 3-12: Supplement Share of Pet Specialty Store Sales
by Animal Category: 2011 (percent)
Table 3-7: Percentage of Pet Specialty Store Sales Volume
Derived from Pet Supplements by Animal Type, 2011
Market Outlook
Positive Trends in Human Supplements Bode Well for Pet Supplements
Pets as Family Trend Bolsters Pet Health/Wellness Spending
Table 3-8: Pet Owner Attitudes and Behavior Characterizing Human/Animal Bond, 2012 (percent)
Table 3-9: Level of Veterinary Expenditures by Human-Animal Bond and Animal Type, 2011 (mean dollar per household)
Figure 3-13: Level of Agreement with Statement: “I buy pet supplements and/or functional treats to make doubly sure that my pet gets all the special nutrition it needs,” 2012(percent)
A Natural Advantage
Figure 3-14: U.S. Retail Sales of Natural Pet Products, 2008, 2012, 2017 (in millions of dollars)
Figure 3-15: Level of Agreement with Statement: “If natural/organic pet products were more available where I shop, I would buy them more often,” 2012 (percent)
Figure 3-16: Level of Agreement with Statement: “I am veryconcerned about the safety of the pet products I buy,” 2012(percent)
Figure 3-17: Level of Agreement with Statement: “I prefer tobuy pet supplements and/or functional treats that are allnaturalor organic,” 2012 (percent)
Pet Med Alternatives
Table 3-10: Level of Agreement with Statement: “I avoid usingpet medications as much as possible”: Dog Owners vs. Cat Owners, 2011 (percent)
Table 3-11: Level of Agreement with Statement: “I prefer to try holistic/natural pet treatments including nutritional supplements before resorting to pet medications”: Dog Owners vs. Cat Owners, 2011 (percent)
Supplements Advancing Among Veterinarians, But They Still Want More Testing
Negative PR
Growing Focus on Therapeutic Pet Foods
Table 3-12: Level of Agreement with Statement: “I believe that pet supplements are more effective than ‘functional’ pet food designed to treat specific health conditions,” 2012 (percent)
Table 3-13: Level of Agreement with Statement: “I believe “functional” pet food designed to treat specific health conditions is more effective than supplements in pill, tablet, liquid, or powder form,” 2012 (percent)
Table 3-14: Level of Agreement with Statement: “I do not use pet supplements because I believe my pet gets all the nutrients it needs from the pet food I buy,” 2012 (percent)
Illustration 3-1: Hill’s Everypeteverytime.com Vet-Targeted Website
Nutraceutical Treats Expanding Market Boundaries
Lack of Product Understanding Hinders Market
Figure 3-18: Level of Agreement with Statement: “I believe that ordinary pet food provides all the nutrition that pets need,” 2012 (percent)
Equine Segment Suffers from Decline in Horse Population
Table 3-15: How Pet Owners View Their Pets by Type of Pet, 2011 (percent)
Regulatory Situation: Status Quo Seems to Working
Pet Market Macrotrends
Pet Ownership and Population Trends
Table 3-16: Household Penetration Rates for Dogs and Cats, 2007-2012 (U.S. households—percent and number in thousands)
The Aging Pet Population
Table 3-17: Age of Dogs and Cats, 2012 (percent of pet owners)
Pet Overweight and Obesity
Table 3-18: Percentage and Number of Overweight and Obese Dogs and Cats, 2011
Figure 3-19: “My pet would be considered overweight or obese,” 2012 (percent)
Pet Owners Still Budget Crunching Post Recession
Table 3-19: Level of Agreement with Statement: “I am spending less on pet products because of the economy,”2010-2012 (percent)
Looking Ahead
Annual Sales Gains Expected to Rise Gradually
Table 3-20: Projected U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Total, Small Animal (Dog, Cat,
Other), Equine, 2012–2017 (in millions of dollars)
Table 3-21: Projected U.S. Retail Sales of Small Animal (Dog, Cat, Other) Pet Supplements and Nutraceutical Treats:
Total, Supplements, Treats, 2012–2017 (in millions of dollars)
Table 3-22: Projected U.S. Retail Sales of Equine
Supplements and Nutraceutical Treats: Total, Supplements,
Treats, 2012–2017 (in millions of dollars)
Table 3-23: Share of U.S. Retail Sales of Pet Supplements and Nutraceutical Treats: Small Animal (Dog, Cat, Other) vs. Equine, 2012–2017 (percent)
Why the Sluggishness?
On a Positive Note
Illustration 3-2: GNC Vitamins & Supplement for Cats Center in PetSmart
Illustration 3-3: GNC Vitamins & Supplement for Cats Center in PetSmart (Closeup)
Figure 3-20: Level of Agreement with Statement: “I would prefer to buy pet supplements under the same human brand names I’m familiar with (such as One-a-Day),” 2012 (percent)
Illustration 3-4: Royal Canin’s New X-Small Dog Pet Food Line
Illustration 3-5: Iams’ New Senior Plus (Age 11+) Pet Foods
Figure 3-21: Pet Supplement Opportunity Gap: Percentage of
Dog or Cat Owners Who Use Human Supplements vs.
Percentage of Dog or Cat Owners Who Buy Pet Supplements, 2012
Chapter 4: Competitive Trends
Most Supplement Companies Focused in Pet Health
Mergers & Acquisitions
Bayer Acquires Teva Animal Health
Perrigo Acquires Sergeant’s
Kemin Acquires Genesis
Unicharm Takes Stake in Hartz (Sumitomo)
Nutri-Vet Acquired by Imperial Capital/Petra Pet
The Honest Kitchen Receives Capital Investments
Quaker Pet Group Acquires Watson’s Senior Pet Supplies
Pet Specialty Channel Marketers
Mass-Market Activity in Pet Supplements: Leading Marketers and Brands
Mass-Market Activity in Nutraceutical Treats: Leading
Marketers and Brands
Table 4-1: SymphonyIRI-Tracked Sales of Pet Supplements, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Table 4-2: SymphonyIRI-Tracked Sales of Nutraceutical Dog Treats, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Table 4-3: SymphonyIRI-Tracked Sales of Nutraceutical Cat Treats, 52 Weeks Ending November 4, 2012 vs. Year-Ago (in thousands of dollars)
Veterinary Channel Marketers and Trends
Patented Formulations
Clinically Proven
Illustration 4-1: GLC Direct’s New Actistatin Joint Supplement
Teva Bounces Back with New Parent and New Products
Illustration 4-2: Teva Animal Health Products Web Page
The French Contingent: Sogeval, Vétoquinol, Virbac
Illustration 4-3: Virbac’s Pet-Tabs Home Page
Channel Cross-Over and Expansion
Illustration 4-4: Tomlyn Pet Supplements and Soft Chews
Illustration 4-5: Nutramax’s New Line of Supplements for Walmart
Illustration 4-6: Nutri-Vet’s Best Pet Health Supplements for the Mass Market
Iams and Merrick Back Out of Pure-Play Supplement Waters, Nestlé Purina Forges Ahead
Illustration 4-7: Nestlé Purina’s FortiFlora Supplement Web Page
Illustration 4-8: Fruitables Canned Supplements for Dogs & Cats
Illustration 4-9: Nature’s Variety Raw Daily Boost Powder Supplements
Novus Ramping Up in Companion Animal Supplements
Illustration 4-10: Promotional Flyer for Novus’s Arenus Supplements
Illustration 4-11: Trade Ad for Novus’s Previda Probiotic Ingredient (Petfood Industry, December 2012)
Private-Label Supplement Range Expanding
Illustration 4-12: Selected PetSmart/GNC Specialty Supplements
Illustration 4-13: GNC Vitamins & Supplement for Dogs Center in PetSmart
Illustration 4-14: Banner Ad for GNC Pets Line on PetSmart.com
Figure 4-1: Level of Agreement with Statement: “I buy pet supplements under the same human supplement brand names I’m familiar with (such as GNC),” 2012 (percent)
Illustration 4-15: Petco’s Pet Supplement Web Page
Illustration 4-16: Petco’s Healthy Select Store-Brand Pet Supplements
Illustration 4-17: Petco Store-Brand Pet Supplements
Illustration 4-18: “Supplement” Results from Butler Schein’s Online Compendium
Table 4-4: Selected Marketers and Brands of Pet Supplements and Nutraceutical Treats, 2012
Chapter 5: Marketing and New Product Trends
Marketing Trends
Advertising and Promotion
Illustration 5-1: Trade Ad for GreenDog Naturals Pet Supplements (Pet Age, October 2011)
Clinically Proven
Illustration 5-2: Trade Ad for ProLabs’ Flex Rx (Pet Business, April 2012)
Nutramax Relies on Celebrities, Including The Lord
Illustration 5-3: Nutramax Videos on YouTube
Nutri-Vet Deploys Award-Winning Animated Videos
Illustration 5-4: Nutri-Vet Animated Videos on YouTube
Vétoquinol Introduces Rewards Program for Veterinarians
Educating Retailers
Table 5-1: Repeat, Impulse, Sale/Promoted, and Comparison-Shopping-Based Purchasing Rates for Pet Supplements vs. Other Types of Nonfood Pet Products, 2012 (percent)
Merchandising
Illustration 5-5: Retail Displays of Tomlyn Supplements and Treats
On the Web
Illustration 5-6: GNC Pet Supplements at GNC.com
Illustration 5-7: Website Banner Link to Online Shopping Options
New Product Trends
Activity Continues, Though at Somewhat Slower Pace
Focus on Felines
Illustration 5-8: Trade Ad for NaturVet’s Condition-Specific Soft Chews for Cats (Pet Business, January 2013)
Illustration 5-9: Mars/Nutro’s Feline Greenies Smartbites Treats Soft Chews, Gels, Pastes, and Other Non-Traditional Forms
Illustration 5-10: NoviPet’s Soft Chew Supplements for Dogs
Illustration 5-11: Trade Ad for Tomlyn’s Gel Supplements for Cats
Illustration 5-12: Synergy Laboratories’ Richard’s Organics 100% Natural Nutrient Pastes
Pet Food Add-Ins
Illustration 5-13: Bergan’s Prudence–Nature’s Wellness Supplement Powders
Illustration 5-14: Trade Ad for The Missing Link Supplement Powders (Pet Age, December, 2012)
Liquid Supplements
Illustration 5-15: Animal Business Concepts’ Cool Pet Hydration Formulas
Condition-Specific Supplements
Illustration 5-16: PetSmart/GNC Nutraceutical Dog Treats
Illustration 5-17: Oxbow Animal Health’s Natural Science
Small Animal Supplements
Joint Support
Illustration 5-18: Steadfast Joint Health Supplement from Arenus (Novus)
Illustration 5-19: Trade Ad for Grizzly Pet Products’ Joint Aid 4 Dogs (Pet Business, December 2012)
Skin & Coat Health
Illustration 5-20: Cardinal Lab’s Full Life Omega Antioxidant Treats
Illustration 5-21: In Clover’s Glow Skin & Coat Soft Chews for Dogs
Illustration 5-22: Vitakraft’s Sunseed Mineral Treats
Calming/Behavior-Control Products
Digestive Health, Immune Support, and Probiotics
Illustration 5-23: Trade Ad for Herbsmith’s Microflora Plus for Digestion for Dogs and Cats (Pet Business, February 2012)
Illustration 5-24: DogGestive Digestive Health Supplement for Dogs
Illustration 5-25: GeneFlora for Pets (and People) Probiotic Supplements
Illustration 5-26: Harrison's Bird Foods’ Avian Enzyme Oral Care/Breath Products
Illustration 5-27: Vetri-Science’s Perio-Support
Weight Loss/Maintenance
Illustration 5-28: Garmon Corp.’s Slim-N-Fit Weight Control Canine Supplement
Liver, Kidney, and Bladder Function
Illustration 5-29: Sogeval’s S-Adenoysl-225 Snap Tablets
Illustration 5-30: Trade Ad for Herbsmith’s Bladder Care Supplements (Pet Business, April 2012)
Senior-Specific
Illustration 5-31: Quaker Pet Group’s Silver Tails Collection of Senior Pet Products
Illustration 5-32: AvidLife Pets’ Nutritional and Lubricant Eye Drops
Multivitamins, Multitasking, and Multipet
Illustration 5-33: Harrisons’ Pet Products’ Sunshine Factor and Booster Supplements
Featured Ingredients Bee Pollen and Bee Propolis
Illustration 5-34: Trade Ad for Ferrera Farms Naturals Bee the Best Supplements (Pet Business, April 2012)
Elk Antler
Illustration 5-35: Trade Ad for Wapiti Laboratories’ Elk Velvet Antler Supplements (Pet Product News International 2013 Annual Buying Guide)
Flax
Green Tea
Illustration 5-36: Consumer Ad for Reishi with Green Tea Immunity Boost Canine Supplement (Animal Wellness,June/July 2012)
Green-Lipped Mussel
Illustration 5-37: Greenies JointCare Treats with Green-Lipped Mussel
Kelp
Mushrooms
Illustration 5-38: Mushroom Matrix’s Equine Matrix and Pet Matrix
Chapter 6: Consumer Trends
Overview of Supplemental Pet Nutrition Products
Table 6-1: Use of Supplemental Pet Nutrition Products by Type: Dog vs. Cat Owners, 2012 (percent)
Consumer Focus: Pet Supplements
Topline Usage Rates Among Dog and Cat Owners
Figure 6-1: Use of Pet Supplements: Dog vs. Cat Owners,2010 vs. 2012 (percent)
Topline Number of Product Purchasers
Over Two-Thirds Use OTC Products
Figure 6-2: Use of OTC Pet Supplements: Dog Owners vs. Cat Owners, 2012 (percent)
Figure 6-3: Use of Vet-Prescribed or Vet-Dispensed Pet Supplements: Dog vs. Cat Owners, 2012 (percent)
Over Half Buy at Pet Superstores
Table 6-2: Purchasing Patterns for Pet Supplements by Retail Channel, 2010 vs. 2012 (percent of U.S. dog or cat owners who use OTC pet supplements)
Petco and Hartz Tied as Top Brands by Usage Rates
Table 6-3: Purchasing Patterns for Pet Supplements by Brand, 2012 (percent of U.S. dog or cat owners who use pet supplements)
Consumer Traits of Pet Supplement Purchasers
Table 6-4a: Use of Pet Supplements by Consumer Trait: Dog Owners, 2012 (percent)
Table 6-4b: Use of Pet Supplements by Consumer Trait: Cat Owners, 2012 (percent)
Joint Health Divides Dog from Cat Segments
Table 6-5: Use of Pet Supplements and Nutraceutical Treats by Type: Dog vs. Cat Owners, 2012 (percent of U.S. dog or cat owners who use pet nutraceutical treats)
Consumer Focus: Nutraceutical Treats
Topline Usage Rates Among Dog and Cat Owners
Figure 6-4: Use of Pet Nutraceutical Treats: Dog vs. Cat Owners, 2012 (percent)
Topline Number of Product Purchasers
Purchasing Patterns: Pet Superstores vs. Walmart
Table 6-6: Purchasing Patterns for Nutraceutical Treats by Retail Channel, 2012 (percent of U.S. dog or cat owners who use OTC pet supplements)
Few Nutraceutical Treats Show up in Experian Simmons Data
Consumer Traits of Pet Nutraceutical Treat Purchasers
Table 6-7a: Use of Pet Nutraceutical Treats by Consumer Trait: Dog Owners, 2012 (percent)
Table 6-7b: Use of Pet Nutraceutical Treats by Consumer Trait: Cat Owners, 2012 (percent)
Historical Usage Rate Trends
Usage of Dog Products Recovers in 2011 and 2012
Figure 6-5: Purchasing Rates for Supplemental Pet Nutrition Products: Dog vs. Cat Owners, Summer 2012 (U.S. dog- or cat-owning households)
Table 6-8: Purchasing Rates for Supplemental Pet Nutrition
Products: Dog vs. Cat Owners, Spring 2005-Spring 2011 (U.S. dog- or cat-owning households)
Usage Rates for Cat Products Hit Bump in the Climb
Table 6-9: Household Income Level Snapshot: Dog vs. Cat Owners, 2012 (U.S. dog- or cat-owning households)
Product Purchaser Demographics
Multiple-Pet Factor Favors Dog Supplement/Nutraceutical
Treat Sales
Table 6-10: Purchasing Rates for Supplemental Pet Nutrition Products by Number of Pets: Dog vs. Cat Owners, 2012 (percent and index for U.S. dog- or cat-owning households)
Table 6-11a: Dog and Cat Ownership Trends by Number of Pets, 2008-2012 (percent of U.S. households)
Table 6-11b: Dog and Cat Ownership Trends by Number of Pets, 2008-2012 (number of U.S. households in thousands)
Demographic Patterns Are Anomalous
Table 6-12: Demographics for Purchasing of Supplemental Pet
Nutrition Products: Dog Owners, 2012 (percent, number of households, and index)
Table 6-13: Demographics for Purchasing of Supplemental Pet Nutrition Products: Cat Owners, 2012 (percent, number of households, and index)
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218313.
Contact sales@reportsandreports.com for further information.
Feb 6, 2013
The Future of LTE: Infrastructure, Applications, and Subscribers 2013 – 2018
The deployment of LTE networks is
progressing with the industrialized nations in North America, Europe and
Asia already deploying operating LTE networks.
This report addresses key issues regarding LTE including operational support systems, architecture, and significant commercial features for consumers and enterprise users. This report provides the reader with critical vision into the future of LTE including the drive for lower priced capacity also driving lower margins for core services leading to the need for value-added services (VAS).
We evaluate these VAS applications supported by new advances in LTE with an emphasis on their market potential in terms of new revenue and enhanced profitability for the mobile network operators in the face of competition from over the top (OTT) players. We also provide vision into the future of LTE in terms of new business paradigms, business model evolution, devices and subscribers, opportunities and threats to the mobile network operators
Buy a copy of this report @ http://www.reportsnreports.com/reports/214522-the-future-of-lte-infrastructure-applications-and-subscribers-2013-2018.html
This report addresses key issues regarding LTE including operational support systems, architecture, and significant commercial features for consumers and enterprise users. This report provides the reader with critical vision into the future of LTE including the drive for lower priced capacity also driving lower margins for core services leading to the need for value-added services (VAS).
We evaluate these VAS applications supported by new advances in LTE with an emphasis on their market potential in terms of new revenue and enhanced profitability for the mobile network operators in the face of competition from over the top (OTT) players. We also provide vision into the future of LTE in terms of new business paradigms, business model evolution, devices and subscribers, opportunities and threats to the mobile network operators
Buy a copy of this report @ http://www.reportsnreports.com/reports/214522-the-future-of-lte-infrastructure-applications-and-subscribers-2013-2018.html
Table of Contents
1 Introduction
2 Fourth Generation (4G) Cellular via LTE
2.1 LTE Technology
2.2 FDD LTE
2.3 TDD LTE (TD-LTE)
2.4 LTE Advanced
2.5 LTE Infrastructure Elements and Architecture Overview
2.6 LTE E-UTRAN Infrastructure Elements and Network Architecture
2.6.1 LTE Remote Radio Heads
2.6.2 LTE Base Station
2.6.3 LTE Femtocells
2.6.4 LTE Antenna Schemes
2.6.5 LTE RAN Infrastructure and Frequency Reuse
2.7 LTE EPC Infrastructure Elements and Network Architecture
2.7.1 Serving and Packet Gateway
2.7.2 Mobility Management Entity
2.7.3 Policy and Charging Rules Function
2.7.4 IP Multimedia Subsystem
2.7.5 EPC and Core Network Equipment Reuse in LTE
2.8 LTE Backhaul Solutions
2.8.1 LTE Backhaul Requirements
2.8.2 Carrier Ethernet
2.8.3 Fiber Backhauls
2.8.4 Microwave Backhauls
2.8.5 Impact of Femtocells on Backhaul
3 Self-Organizing Networks (SON)
3.1 Introduction
3.2 Why SON for LTE?
3.2.1 IEEE 802.16
3.2.2 SON NGMN Standards
3.2.3 SON Categories and Use Cases
3.2.4 Distributed/Self-organizing (DSO)
3.2.5 Cooperative Relaying (CR) in SON
3.2.6 Feedback Overhead in SON
3.2.7 Codebook-Based Pre-coding in SON
3.2.8 SON Feedback Delay
3.3 SON Implementation
3.4 SON Implementation Staging
3.4.1 Self-Configuration
3.4.2 Self-Optimization
3.4.3 Self-Healing
3.4.4 Self-Healing Challenges
3.4.5 Installation Phases
4 LTE Applications
4.1 VoLTE
4.2 Video
4.3 RCS
4.4 Public Safety
4.5 LTE Direct
5 LTE Deployment Strategies
5.1 Strategy for 3G in an LTE World
5.2 Network Sharing
5.3 LTE Devices
5.4 LTE Architecture Strategies
5.4.1 Small Cells
5.4.2 LTE and IMS
6 Future of LTE
6.1 Devices and Subscribers
6.2 New Paradigms
6.3 New Business Models
6.4 New Applications
6.5 Dangers for the Carrier
6.6 Opportunities for the Carrier
6.7 New Market Entrant
Contact sales@reportsandreports.com for further information.
1 Introduction
2 Fourth Generation (4G) Cellular via LTE
2.1 LTE Technology
2.2 FDD LTE
2.3 TDD LTE (TD-LTE)
2.4 LTE Advanced
2.5 LTE Infrastructure Elements and Architecture Overview
2.6 LTE E-UTRAN Infrastructure Elements and Network Architecture
2.6.1 LTE Remote Radio Heads
2.6.2 LTE Base Station
2.6.3 LTE Femtocells
2.6.4 LTE Antenna Schemes
2.6.5 LTE RAN Infrastructure and Frequency Reuse
2.7 LTE EPC Infrastructure Elements and Network Architecture
2.7.1 Serving and Packet Gateway
2.7.2 Mobility Management Entity
2.7.3 Policy and Charging Rules Function
2.7.4 IP Multimedia Subsystem
2.7.5 EPC and Core Network Equipment Reuse in LTE
2.8 LTE Backhaul Solutions
2.8.1 LTE Backhaul Requirements
2.8.2 Carrier Ethernet
2.8.3 Fiber Backhauls
2.8.4 Microwave Backhauls
2.8.5 Impact of Femtocells on Backhaul
3 Self-Organizing Networks (SON)
3.1 Introduction
3.2 Why SON for LTE?
3.2.1 IEEE 802.16
3.2.2 SON NGMN Standards
3.2.3 SON Categories and Use Cases
3.2.4 Distributed/Self-organizing (DSO)
3.2.5 Cooperative Relaying (CR) in SON
3.2.6 Feedback Overhead in SON
3.2.7 Codebook-Based Pre-coding in SON
3.2.8 SON Feedback Delay
3.3 SON Implementation
3.4 SON Implementation Staging
3.4.1 Self-Configuration
3.4.2 Self-Optimization
3.4.3 Self-Healing
3.4.4 Self-Healing Challenges
3.4.5 Installation Phases
4 LTE Applications
4.1 VoLTE
4.2 Video
4.3 RCS
4.4 Public Safety
4.5 LTE Direct
5 LTE Deployment Strategies
5.1 Strategy for 3G in an LTE World
5.2 Network Sharing
5.3 LTE Devices
5.4 LTE Architecture Strategies
5.4.1 Small Cells
5.4.2 LTE and IMS
6 Future of LTE
6.1 Devices and Subscribers
6.2 New Paradigms
6.3 New Business Models
6.4 New Applications
6.5 Dangers for the Carrier
6.6 Opportunities for the Carrier
6.7 New Market Entrant
Contact sales@reportsandreports.com for further information.
Market Attractiveness and Future Prospects of the Saudi Arabian Takaful Insurance Industry
Saudi Arabia’s Takaful insurance industry is
the largest Takaful industry in the world. Robust economic growth,
increasing annual disposable income, favorable demographics,
introduction of compulsory insurances and government expenditure on
infrastructure present a significant business opportunity and positive
growth potential over the forecast period. Furthermore, increasing
awareness of Takaful insurance and the non-existence of conventional
insurance supported the growth of the industry in the country. The
outlook for the industry remains positive for the life, non-life, and
personal accident and health insurance segments. Premiums in all the
segments are expected to increase at respectable rates in line with
economic growth.
Scope
This report provides a comprehensive analysis of the Takaful insurance market in Saudi Arabia:
Scope
This report provides a comprehensive analysis of the Takaful insurance market in Saudi Arabia:
- It provides historical values for the Saudi Arabian Takaful insurance market for the report’s 2007–2011 review period and forecast figures for the 2012–2016 forecast period
- It offers a detailed analysis of the key segments and sub-segments in the Saudi Arabian Takaful insurance market, along with market forecasts until 2016
- It covers an exhaustive list of parameters, including gross written premium, premium per capita, number of active policies, insurance penetration (percentage of GDP), paid claims, incurred loss, loss ratio, commissions and expenses, combined ratio, total assets, investments, total investment income and retentions.
- It outlines the key regulations affecting the overall Saudi Arabian Takaful insurance market
- Make strategic business decisions using in depth historic and forecast market data related to the Saudi Arabian Takaful insurance industry and each segment within it
- Understand the demand-side dynamics, key market trends and growth opportunities within the Saudi Arabian Takaful insurance market
- Identify the growth opportunities and market dynamics within key segments
- Gain insights into key regulations governing the Saudi Arabian Takaful insurance market and its impact on companies and the industry''s future
- Saudi Arabia’s Takaful insurance industry is the largest Takaful industry in the world.
- Strong economic fundamentals and favorable demographics support the growth of Takaful insurance in Saudi Arabia.
- The Takaful insurance industry in Saudi Arabia is regulated by the Saudi Arabian Monetary Agency (SAMA) through its Insurance Supervision Department.
- The health insurance and motor insurance categories are expected to remain the key growth drivers for the Takaful insurance industry.
- According to the Saudi Arabian Monetary Authority (SAMA), there are 33 Takaful insurance and reinsurance companies operating in Saudi Arabia, both domestic and international.
- Takaful insurance companies in Saudi Arabia focused on customer segments by offering customized products.
Challenges and Opportunities for the Wealth Sector in Turkey 2013
This report is a thorough analysis of the Turkish Wealth Management
and Private Banking sector and the opportunities and challenges that it
faces.
Scope
Reasons To Buy
Scope
- Independent market sizing of Turkish HNWIs across five wealth bands
- Number of wealth managers in each city
- City wise ratings of wealth management saturation and potential
- Details of the development, challenges and opportunities of the Wealth Management and Private Banking sector in Turkey
- Size of the Turkish wealth management industry
- Detailed wealth management and family office information
- Insights into the drivers of HNWI wealth
Reasons To Buy
- The WealthInsight Intelligence Center Database is an unparalleled resource and the leading resource of its kind. Compiled and curated by a team of expert research specialists, the Database comprises profiles on major private banks, wealth managers and family offices in each country.
- The WealthInsight Intelligence Center Database also includes up to one hundred data-points on over 100,000 HNWIs from around the world.
- With the Database as the foundation for our research and analysis, we are able obtain an unsurpassed level of granularity, insight and authority on the HNWI and wealth management universe in each of the countries and regions we cover.
- Report includes comprehensive forecasts to 2017.
- There were just over 94,000 HNWIs in Turkey in 2012. These HNWIs held US$500 billion in wealth, which equates to 43% of total individual wealth held in the country.
- Turkish HNWIs outperformed the worldwide HNWI average during the review period – worldwide HNWI volumes decreased by 0.3% whilst Turkish HNWI numbers rose by 7.4%.
- In 2012, Turkish HNWI numbers rose by 23.2%, following a drop of 6.1% in 2011.
- Turkey is seen as a core emerging European wealth management market, after a decade of political stability and economic progress under the AKP government elevated Turkey’s position in the eyes of international investors and wealth managers.
- Investors from the Gulf region, Russia and former Turkic Republics account for a major share of the potential investor base.
- As of 2012, there are 28 private banks active in Turkey.
- The largest domestic private banks are Garanti and Yapı Kredi.
Global Earthmoving Equipment – Market Opportunity and Environment, Analyses and Forecasts to 2016
The global earthmoving equipment market valued US$78.7 billion in
2011, of which the Asia-Pacific market constituted a 57.8% share, making
it the largest regional market for earthmoving equipment in the world.
In the same year, markets in Europe and North America positioned
themselves as the second and third-largest regional markets, with 22.0%
and 12.4% shares respectively. The continuing economic uncertainty in
Europe and sluggish growth in the US are expected to reduce the market
shares of western regions. Growing economies in Asia-Pacific, in
particular China and India, are expected to increase their market shares
as the rapid development of their infrastructural, industrial,
residential and commercial sectors increases the demand for construction
equipment. The share of European and North American markets is expected
to be 18.2% and 9.8% respectively in 2016, declining from 22.0% and
12.4% in 2011, while Asia-Pacific is forecast to increase its share to
64.5% in the same year.
Scope
This report provides a comprehensive analysis of the earthmoving equipment market globally:
Reasons To Buy
Scope
This report provides a comprehensive analysis of the earthmoving equipment market globally:
- Historical (2007-2011) and forecast (2012-2016) valuations of the earthmoving equipment market in Asia-Pacific, Middle East, Europe, North America, Latin America
- Historical and forecast valuations for the segments of the earthmoving equipment market including Bulldozers, Excavators, Dumper Trucks, Construction Tractors, Graders and Levelers, Loaders and Scrapers
- Breakdown of values at the country level (44 countries)
- Analysis of key events and factors driving the earthmoving equipment market globally
Reasons To Buy
- Identify and evaluate market opportunities using our standardized valuation and forecasting methodologies
- Assess market growth potential at a micro-level via review data and forecasts at category and country level
- Understand the latest industry and market trends
- Formulate and validate business strategies by leveraging our critical and actionable insight
- Assess business risks, including cost and competitive pressures
- The global earthmoving equipment market valued US$78.7 billion in 2011, of which the Asia-Pacific market constituted a 57.8% share, making it the largest regional market for earthmoving equipment in the world.
- In terms of growth, the global earthmoving equipment market recorded a CAGR of 2.50% during the review period (2007-2011). The key contributor to this low growth rate was the 23.9% decline in annual growth rate recorded in 2009.
- The Asian earthmoving equipment market valued US$45.5 billion in 2011. The Chinese market constituted the largest share with 56.9%.
- A strong pipeline of various infrastructure, industrial, residential, commercial and institutional construction projects in Asia-Pacific will drive demand for earthmoving equipment. As a result, the global earthmoving equipment market is estimated to record a CAGR of 7.98% over the forecast period to value US$115.5 billion in 2016.
- China is one of the fastest-growing construction equipment markets in the world. In terms of total global sales of construction equipment, the share of China’s construction equipment sales increased from 9% in 2005 to 40% in 2010.
HNWI Asset Allocation in Turkey 2013
This report provides the latest asset allocations of Turkish HNWIs
across 13 asset classes. The report also includes projections of the
volume, wealth and asset allocation of Turkish HNWIs to 2017 and a
comprehensive and robust background of the local economy.
Scope
Reasons To Buy
Scope
- Independent market sizing of Turkish HNWIs across five wealth bands
- HNWI volume, wealth and allocation trends from 2007 to 2012
- HNWI volume, wealth and allocation forecasts to 2017
- HNWI and UHNWI asset allocations across 13 asset classes
- Insights into the drivers of HNWI wealth
Reasons To Buy
- The WealthInsight Intelligence Center Database is an unparalleled resource and the leading resource of its kind. Compiled and curated by a team of expert research specialists, the Database comprises profiles on major private banks, wealth managers and family offices in each country.
- The WealthInsight Intelligence Center Database also includes up to one hundred data-points on over 100,000 HNWIs from around the world.
- With the Database as the foundation for our research and analysis, we are able obtain an unsurpassed level of granularity, insight and authority on the HNWI and wealth management universe in each of the countries and regions we cover.
- Report includes comprehensive forecasts to 2017.
- There were just over 94,000 HNWIs in Turkey in 2012. These HNWIs held US$500 billion in wealth, which equates to 43% of total individual wealth held in the country.
- In 2012, business interests were the largest asset class for HNWIs in Turkey (24% of total HNWI assets), followed by equities (22%), fixed income (19.6%), real estate (18.4%), cash (11.8%) and alternatives (4.3%).
- Fixed income products recorded the strongest growth over the review period, driven by a movement into safer assets and relatively high local savings rates.
- As of 2012, HNWI liquid assets amounted to US$103 billion, representing 20.7% of the wealth holdings of Turkish HNWIs.
- WealthInsight’s research showed that in 2012, 39% of Turkish HNWIs had second homes abroad. The primary locations for these homes included Geneva, Zurich, Paris and London.
- At the end of 2012, Turkish HNWIs held 26.6% (US$138 billion) of their wealth outside their home country, which is in line with the worldwide norm of between 20% and 30%.
Feb 5, 2013
ReportsnReports: FMC in the Global Agrochemical Sector
New market research report on "Competitive Intelligence: FMC in the Global Agrochemical Sector" to its store.
This strategic assessment of FMC, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218447.
Table of Contents
Section I: Executive Summary
A 3-5 page synopsis of key sections.
Section II: Business Organization
History of the company’s agrochemical business evolution, which is important to understanding
the corporate culture, management mentality and strategies.
Recent acquisitions, divestitures and major organizational changes.
Current organizational structure.
Section III: Senior Management
Names, titles and background of key executives.
Section IV: Facilities And Employees
Administrative, manufacturing and R&D facilities in the U.S. and abroad.
Manufacturing practices.
New plants under construction.
The U.S. and international work force size and distribution.
Section V: Technological Know-How
Internally developed and acquired agrochemical and related capabilities.
Proprietary technologies and patent litigation.
Section VI: Product Portfolio
Review of major product lines.
Applications, advantages and weaknesses of leading products.
Section VII: Marketing Tactics
Promotional tactics.
Distribution approaches.
Product service and support.
Customer relations.
Section VIII: Financial Analysis
Estimated sales by division, geographic region and product line. .
Five-year sales and operating profit performance.
Section IX: R&D Expenditures And Major Programs
Estimated R&D budget.
Research facilities and staff.
New technologies, products and applications in development.
Section X: Collaborative Arrangements
Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.
Section XI: Strategic Direction
Specific business, new product development and marketing strategies.
Anticipated acquisitions, joint ventures and divestitures.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218447.
Contact sales@reportsandreports.com for further information.
This strategic assessment of FMC, one of the world's leading agrochemical companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The new report from Venture Planning Group presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global agrochemical market.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218447.
Table of Contents
Section I: Executive Summary
A 3-5 page synopsis of key sections.
Section II: Business Organization
History of the company’s agrochemical business evolution, which is important to understanding
the corporate culture, management mentality and strategies.
Recent acquisitions, divestitures and major organizational changes.
Current organizational structure.
Section III: Senior Management
Names, titles and background of key executives.
Section IV: Facilities And Employees
Administrative, manufacturing and R&D facilities in the U.S. and abroad.
Manufacturing practices.
New plants under construction.
The U.S. and international work force size and distribution.
Section V: Technological Know-How
Internally developed and acquired agrochemical and related capabilities.
Proprietary technologies and patent litigation.
Section VI: Product Portfolio
Review of major product lines.
Applications, advantages and weaknesses of leading products.
Section VII: Marketing Tactics
Promotional tactics.
Distribution approaches.
Product service and support.
Customer relations.
Section VIII: Financial Analysis
Estimated sales by division, geographic region and product line. .
Five-year sales and operating profit performance.
Section IX: R&D Expenditures And Major Programs
Estimated R&D budget.
Research facilities and staff.
New technologies, products and applications in development.
Section X: Collaborative Arrangements
Joint ventures, distribution, O.E.M. and licensing partners, both industrial and academic.
Terms of collaborative agreements and specific products involved.
Section XI: Strategic Direction
Specific business, new product development and marketing strategies.
Anticipated acquisitions, joint ventures and divestitures.
Request a sample before buying a copy of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218447.
Contact sales@reportsandreports.com for further information.
ReportsnReports: 2016 Global Surgical Equipment Market
ReportsnReports adds new market research on "Global Surgical Equipment Market 2012-2016" to its store.
TechNavio''s analysts forecast the Global Surgical Equipment market to grow at a CAGR of 6.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for minimally invasive surgery. The Global Surgical Equipment market has also been witnessing vendors shifting to absorbable sutures. However, the slow growth of the Surgical Equipment market in the US could pose a challenge to the growth of this market.
TechNavio''s report, the Global Surgical Equipment Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Surgical Equipment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Becton Dickinson and Company, Boston Scientific Corp., Covidien Plc, Ethicon Inc., and Medtronic Inc.
The other vendors mentioned in the report are B. Braun Melsungen AG, MEDICON eG, ERBE Elektromedizin GmbH, Conmed Corp., Integra LifeSciences Corp., Codman and Shurtleff Inc., and KLS Martin Group GmbH and Co. KG.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio''s research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=212037.
Published: December 2012
No. of Pages: 54
Price: Single User: US $ 2500 Corporate User: US $ 3500
Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Products
04. Market Landscape
04.1 Global Surgical Equipment Market
Market Size
Market Forecast
04.2 Surgical Equipment Market in the US
Market Size and Forecast
04.3 Key Market Segmentation
04.4 Global Surgical Sutures Market
Market Size and Forecast
04.5 Global Electrosurgical Equipment Market
Market Size and Forecast
04.6 Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
US
Germany
China
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Ethicon Inc.
Business Overview
SWOT Analysis
14.2 Becton Dickinson and Co.
Business Overview
SWOT Analysis
14.3 Medtronic Inc.
Business Overview
SWOT Analysis
14.4 Covidien plc
Business Overview
SWOT Analysis
14.5 Boston Scientific Corp.
Business Overview
SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
Contact sales@reportsandreports.com for further information.
TechNavio''s analysts forecast the Global Surgical Equipment market to grow at a CAGR of 6.25 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increasing demand for minimally invasive surgery. The Global Surgical Equipment market has also been witnessing vendors shifting to absorbable sutures. However, the slow growth of the Surgical Equipment market in the US could pose a challenge to the growth of this market.
TechNavio''s report, the Global Surgical Equipment Market 2012-2016, has been prepared based on an in-depth market analysis of the market with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the Global Surgical Equipment market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
The key vendors dominating this market space are Becton Dickinson and Company, Boston Scientific Corp., Covidien Plc, Ethicon Inc., and Medtronic Inc.
The other vendors mentioned in the report are B. Braun Melsungen AG, MEDICON eG, ERBE Elektromedizin GmbH, Conmed Corp., Integra LifeSciences Corp., Codman and Shurtleff Inc., and KLS Martin Group GmbH and Co. KG.
Key questions answered in this report:
What will the market size be in 2016 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
You can request one free hour of analyst time when you purchase this report. Details provided within the report.
TechNavio''s research portfolio in the Healthcare series includes reports on the Pharmaceutical Market, Medical Devices Market, Diagnostic Market, Vaccine Market, Oncology Market, CRO Market, Orthopedic Market, Hearing Aids Market, Dental Care Market, Medical Imaging Market, Endoscopy Market, Dialysis Market, Telemedicine Market, Cancer Drug Market, Glucose Monitoring Market, Infusion Pumps Market, Defibrillators Market, Neuromodulation Market, Capnography Market.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=212037.
Published: December 2012
No. of Pages: 54
Price: Single User: US $ 2500 Corporate User: US $ 3500
Table of Contents
01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Key Products
04. Market Landscape
04.1 Global Surgical Equipment Market
Market Size
Market Forecast
04.2 Surgical Equipment Market in the US
Market Size and Forecast
04.3 Key Market Segmentation
04.4 Global Surgical Sutures Market
Market Size and Forecast
04.5 Global Electrosurgical Equipment Market
Market Size and Forecast
04.6 Five Forces Analysis
05. Geographical Segmentation
06. Key Leading Countries
US
Germany
China
07. Vendor Landscape
08. Buying Criteria
09. Market Growth Drivers
10. Drivers and their Impact
11. Market Challenges
12. Impact of Drivers and Challenges
13. Market Trends
14. Key Vendor Analysis
14.1 Ethicon Inc.
Business Overview
SWOT Analysis
14.2 Becton Dickinson and Co.
Business Overview
SWOT Analysis
14.3 Medtronic Inc.
Business Overview
SWOT Analysis
14.4 Covidien plc
Business Overview
SWOT Analysis
14.5 Boston Scientific Corp.
Business Overview
SWOT Analysis
15. Other Reports in this Series
List of Exhibits:
Contact sales@reportsandreports.com for further information.
Feb 4, 2013
Leading Specialty Chemicals Companies Strategic Directions
This new report from Venture Planning Group provides strategic directions of leading specialty chemicals companies.
The report presents insightful strategic assessments, including:
The report presents insightful strategic assessments, including:
- Specific business, new product development and marketing strategies.
- Strengths and weaknesses.
- Anticipated acquisitions, joint ventures and divestitures.
Buy a copy of this report @ http://www.reportsnreports.com/reports/218299-competitive-intelligence-leading-specialty-chemicals-companies-strategic-directions.html
Report Details:
Published: January 2013
No. of Pages: 56
Price:Single User License:US$2850 Corporate User License:US$6300
Request a Sample of this report to get a comprehensive Table of Contents @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218299
The U.S. Market for Vascular Access Devices and Accessories was nearly $4 billion in 2012
In 2012, the U.S. market for vascular
access devices and accessories was nearly $4 billion, a 6.1% increase
over the previous year.
The vascular access device market includes implantable ports, port or Huber needles, central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs), midlines and peripheral intravenous catheters (PIVCs). The market also includes hand-carried and portable ultrasound systems, ultrasound guidance systems used for vascular access, catheter securement devices, and syringes and needles. The total market for vascular access devices is expected to grow at a high-single-digit rate over the forecast period, exceeding $6 billion by 2019.
Scope:
This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218230
Report Details:
Published: February 2013
No. of Pages: 354
Price:Single User License:US$6995 Corporate User License:US$8995
Report Contents:
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
The vascular access device market includes implantable ports, port or Huber needles, central venous catheters (CVCs), dialysis catheters, peripherally inserted central catheters (PICCs), midlines and peripheral intravenous catheters (PIVCs). The market also includes hand-carried and portable ultrasound systems, ultrasound guidance systems used for vascular access, catheter securement devices, and syringes and needles. The total market for vascular access devices is expected to grow at a high-single-digit rate over the forecast period, exceeding $6 billion by 2019.
Scope:
This report pertains to a forecast period of 10 years (2009 – 2019) for the U.S.
Buy a copy of this report @ http://www.reportsnreports.com/Purchase.aspx?name=218230
Report Details:
Published: February 2013
No. of Pages: 354
Price:Single User License:US$6995 Corporate User License:US$8995
Report Contents:
- Competitor Analysis
- Identified Strategic Opportunities
- Market Overview by Segment & Country
- Trend Analysis by Segment & Country
- Market Drivers & Limiters
- Mergers & Acquisitions
- Customer Feedback and Market Monitoring
- Implantable ports
- Huber needles
- Central venous catheters (CVCs)
- Dialysis catheters
- Peripherally inserted central catheters (PICCs)
- Midlines
- Peripheral intravenous catheters (PIVCs)
- Ultrasound systems used for vascular access
- Catheter securement devices
- Syringes
- Needles
- Cook Medical
- Siemens Medical Solutions
- Edwards LifeSciences
- AngioDynamics/Navilyst Medical
- Medcomp
- GE Healthcare
- Retractable Technologies Inc.
- B. Braun
- Terumo Medical
- Becton Dickinson
- C. R. Bard
- Vygon
- Centurion Medical Products
- Zefon International
- Kawasumi
- Nipro Medical
- Esaote North America
- Zonare
- Covidien
- Teleflex Medical
- Smiths Medical
- SonoSite
- C. R. Bard
This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “bottom up” approach, which includes primary and secondary research methods.
Contact sales@reportsandreports.com for further information.
Chinese Markets for Methionine Research Report
Buy China's demand for methionine has grown at a fast pace in the past
decade. In the next five years, both production and demand will continue
to grow. This new study examines China's economic trends, investment
environment, industry development, supply and demand, industry capacity,
industry structure, marketing channels and major industry participants.
Historical data (2002, 2007 and 2012) and long-term forecasts through
2017 and 2022 are presented. Major producers in China are profiled.
Buy a copy of this report @ http://www.reportsnreports.com/reports/10652-chinese-markets-for-methionine.html
Report Details:
Published: February 2013
No. of Pages: 170
Price:Single User License:US$2000 Corporate User License:US$4000
Few Major points from TABLE OF CONTENTS
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. METHIONINE INDUSTRY ASSESSMENTS
IV. METHIONINE PRODUCTION AND DEMAND
V. CHIAN METHIONINE MARKETS OUTLOOK
VI. MARKET ENTRY CHANNELS
VII. METHIONINE PRODUCER DIRECTORY
LIST OF TABLES
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. METHIONINE INDUSTRY ASSESSMENTS
IV. PRODUCTION AND DEMAND
V. CHIAN METHIONINE MARKETS OUTLOOK
VI. MARKETING STRATEGIES
LIST OF CHARTS
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. METHIONINE INDUSTRY ASSESSMENTS
IV. METHIONINE PRODUCTION AND DEMAND
V. CHINA METHIONINE MARKETS OUTLOOK
Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=10652
Buy a copy of this report @ http://www.reportsnreports.com/reports/10652-chinese-markets-for-methionine.html
Report Details:
Published: February 2013
No. of Pages: 170
Price:Single User License:US$2000 Corporate User License:US$4000
Few Major points from TABLE OF CONTENTS
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. METHIONINE INDUSTRY ASSESSMENTS
IV. METHIONINE PRODUCTION AND DEMAND
V. CHIAN METHIONINE MARKETS OUTLOOK
VI. MARKET ENTRY CHANNELS
VII. METHIONINE PRODUCER DIRECTORY
LIST OF TABLES
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. METHIONINE INDUSTRY ASSESSMENTS
IV. PRODUCTION AND DEMAND
V. CHIAN METHIONINE MARKETS OUTLOOK
VI. MARKETING STRATEGIES
LIST OF CHARTS
I. INTRODUCTION
II. BUSINESS ENVIRONMENT
III. METHIONINE INDUSTRY ASSESSMENTS
IV. METHIONINE PRODUCTION AND DEMAND
V. CHINA METHIONINE MARKETS OUTLOOK
Request a Sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=10652
Traditional Wound Management Market Outlook in BRICS to 2018
GlobalData’s new report, “Traditional Wound
Management Market Outlook in BRICS (Brazil, Russia, India, China, South
Africa) to 2018” provides key market data on the Traditional Wound
Management market in the BRICS countries. The report provides value
($m), volume (units) and average price ($) data for each segment and
sub-segment within three market categories – Gauzes, Sponges and
Bandages. The report also provides company shares and distribution
shares data for the overall Traditional Wound Management market in each
of the aforementioned countries. The report is also supplemented with
global corporate-level profiles of the key market participants with
information on key developments, wherever available.
The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope
- Market size data for Traditional Wound Management market categories – Gauzes, Sponges and Bandages.
- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the three market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
- 2011 company shares and distribution shares data for the overall Traditional Wound Management market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Traditional Wound Management market in BRICS.
- Key players covered include Cremer SA, Paul Hartmann AG, Johnson & Johnson, B. Braun Melsungen AG, Covidien plc, Molnlycke Health Care AB, Hollister Incorporated and Synergy Health plc.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Traditional Wound Management competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Request a sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218157
The emerging economies, comprising China, India, Brazil, Russia and South Africa, with a significantly large pool of under-served patients, represent the next big opportunity for the leading medical equipment and devices manufacturers. China remains the world’s most populous country and is consequently home to a large patient base. The country is home to more than 120 million people who are aged 65 or older—a population in continuous need of medical care. India, the second most populous country globally, is home to 1.2 billion people, approximately 5% of which are aged 65 or older. It’s estimated that shortly after 2020, India’s population will surpass China, making it the most populous country in the world. As the population continues to grow and people continue to age, the underlying demand for healthcare is also expected to increase.
Scope
- Market size data for Traditional Wound Management market categories – Gauzes, Sponges and Bandages.
- Annualized market revenues ($m), volume (units) and average price ($) data for each of the segments and sub-segments within the three market categories. Data from 2004 to 2011, forecast forward for seven years to 2018.
- 2011 company shares and distribution shares data for the overall Traditional Wound Management market in each of the aforementioned countries.
- Global corporate-level profiles of key companies operating within the Traditional Wound Management market in BRICS.
- Key players covered include Cremer SA, Paul Hartmann AG, Johnson & Johnson, B. Braun Melsungen AG, Covidien plc, Molnlycke Health Care AB, Hollister Incorporated and Synergy Health plc.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Traditional Wound Management competitive landscape in BRICS.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what’s the most preferred mode of product distribution – Identify, understand and capitalize.
Request a sample of this report @ http://www.reportsnreports.com/contacts/RequestSample.aspx?name=218157
